FDA rejects Merck's Vioxx successor - Canada.com
April 27, 2007 Canada.com | FDA rejects Merck's Vioxx successor Canada.com, Canada - US studies of 90-milligram doses of Arcoxia -- the dose widely used overseas to treat rheumatoid arthritis -- have linked Arcoxia to elevated rates of blood ... |
‘Frozen shoulder’ can limit outdoor activities - The State
April 27, 2007| ‘Frozen shoulder’ can limit outdoor activities The State, SC - Diabetes, thyroid disease, autoimmune disease such as rheumatoid arthritis, previous arm or chest surgery, and prolonged immobilization, such as after a ... |